SilverArc Capital

SilverArc Capital is a private equity firm based in Boston, Massachusetts, focusing on healthcare investments. The firm engages in a wide range of investment stages, including seed, early stage, series A and B, growth, late stage, pre-IPO, buyout, turnaround, and distressed situations. Its portfolio spans multiple industries such as biotechnology, healthcare, health diagnostics, genetics, medical, pharmaceutical, therapeutics, and agriculture. SilverArc Capital's investment sizes typically range from $50 million to $100 million, reflecting its commitment to substantial healthcare ventures.

The firm's investment strategy is characterized by a diversified approach, targeting companies at various stages of development and across multiple sectors within the healthcare industry. This broad focus allows SilverArc Capital to leverage opportunities in both emerging and established markets, aiming to drive growth and innovation in the healthcare sector.

SilverArc Capital's portfolio includes investments in companies like Aardvark Therapeutics, a late-stage venture in health care and therapeutics, and Modulight Biotherapeutics, a biotechnology firm. These investments underscore the firm's dedication to advancing healthcare solutions through strategic partnerships and capital infusion.